Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02440659 · ClinicalTrials.gov registry record
Empowering Patients on Choices for Renal Replacement Therapy (Aim 2)
A clinical trial of Chronic Kidney Disease, sponsored by Arbor Research Collaborative for Health.
- Completed
- Registry status
- 2,946
- Enrollment target
- 1
- Study location
NCT02440659: Completed study of Chronic Kidney Disease, sponsored by Arbor Research Collaborative for Health.
NCT02440659 is a study of Chronic Kidney Disease that has completed, run by Arbor Research Collaborative for Health. The registered enrollment target is 2,946 participants, roughly in line with the 3,178-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02440659, a study of Chronic Kidney Disease, has completed, sponsored by Arbor Research Collaborative for Health.
- COMPLETED
- Registry status
- 2,946 participants
- Enrollment target
- 1
- Study location
Study Summary
Empowering Patients On Choices for Renal Replacement Therapy (EPOCH-RRT) study seeks to identify factors that matter the most to patients with kidney disease and study how they are impacted by different types of dialysis. The inclusion of patients, caregivers, and patient advocacy organizations as research partners will assure that the study addresses questions of greatest relevance to patients facing the need for dialysis. Aim two is based on preliminary results of Aim one interviews, and in collaboration with the Patient Advisory Panel, the investigators developed a brief questionnaire to be administered to participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS) and Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Two separate versions of the questionnaire were created to reflect unique aspects of in-center hemodialysis (HD) and peritoneal dialysis (PD).
Primary Outcome
% of patients very much or extremely affected by dialysis
Conditions Studied
Study Locations (1)
Michigan
- Arbor Research Collaborative for Health - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,946 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-12 |
What the finished NCT02440659 record still lists
NCT02440659 is an observational study that tracks outcomes without assigning an intervention. Its 2,946 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 3,178-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target.
The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02440659 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT02440659 about?
NCT02440659 is a clinical study titled "Empowering Patients on Choices for Renal Replacement Therapy (Aim 2)". Empowering Patients On Choices for Renal Replacement Therapy (EPOCH-RRT) study seeks to identify factors that matter the most to patients with kidney disease and study how they are impacted by different types of dialysis. The inclusion of patients, caregivers, and patient advocacy organizations as r...
What is the current status of trial NCT02440659?
This trial is currently completed. The enrollment target is 2,946 participants. The study started on 2015-02. Estimated completion is 2015-12.
What conditions does trial NCT02440659 study?
This clinical trial studies the following conditions: Chronic Kidney Disease.
Who is sponsoring clinical trial NCT02440659?
This trial is sponsored by Arbor Research Collaborative for Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02440659 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02440659's enrollment target sits among peer trials
2,946 10th of 101 higher than 92 of 101 other Chronic Kidney Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
RECRUITING · Phase 2
-
Patient-driven Management of BP in CKD
RECRUITING · Phase 3
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Safety of Short-course of NSAIDs in Pediatric Patients With CKD
RECRUITING · Phase 4
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05849961 · 2,946 participants
Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)
- NCT03331380 · 2,950 participants · NA
Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System
- NCT05564377 · 2,900 participants · Phase 2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- NCT07222995 · 2,900 participants · NA
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia